KLRK1 and neoplasm: VPA reduces the cytotoxicity of NK cells in response to other cytokines including IL-12, IL-15, and IL-18, by downregulating NKG2D and NKp46 expression and inducing apoptosis, preventing NK cells from eradicating K562 tumor cells [105].